TP
ELV icon

Theleme Partners’s Elevance Health ELV Stock Holding History

Theleme Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-330,192
Closed -$126M – 9
2021
Q2 		$126M Buy
330,192
+67,800
+26% +$25.9M 3.68% 8
2021
Q1 		$94.2M Sell
262,392
-17,608
-6% -$5.66M 3.15% 10
2020
Q4 		$89.9M Sell
280,000
-20,000
-7% -$6.14M 2.95% 14
2020
Q3 		$80.6M Hold
300,000
– – 3.7% 12
2020
Q2 		$78.9M Buy
300,000
+162,000
+117% +$43.2M 3.72% 10
2020
Q1 		$31.3M Buy
+138,000
New +$37.6M 2.25% 13

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Theleme Partners's ELV Position: Q3 2021 in Review

Theleme Partners sold out of Elevance Health (ELV) in Q3 2021, closing a stake of 330,192 shares — an estimated $126M sold.

Theleme Partners first reported a position in ELV in Q1 2020 and held it in 6 quarters. The position peaked at $126M in Q2 2021. 1,215 funds tracked by Wall St. Rank hold ELV as of Q3 2021.

  • Theleme Partners reported no remaining Elevance Health position as of Q3 2021 after selling out during the quarter.
  • Theleme Partners sold 330,192 Elevance Health shares in Q3 2021, an estimated $126M.
  • Theleme Partners first reported a position in Elevance Health in Q1 2020 and held it in 6 quarters.
  • Theleme Partners's Elevance Health position peaked at $126M in Q2 2021.
  • 1,215 funds tracked by Wall St. Rank held Elevance Health as of Q3 2021.

Based on Theleme Partners's 13F filing for Q3 2021, filed 15 Nov 2021.